Home / Research library / NAD+ / MOTS-c / 5-Amino-1MQ
NAD+ / MOTS-c / 5-Amino-1MQ: molecular data, studies & sources
NAD+ / MOTS-c / 5-Amino-1MQ is catalogued here as a combination of ingredients. This profile brings together the molecular source record, selected indexed publications and available supplier comparisons. Evidence for a named substance does not authenticate a commercial product.
Compiled by PeptideTech Editors · Sources checked · Selected bibliography, not a systematic review
Molecular formula, weight & structure
A blend is not one molecule
This is a combination of separate ingredients, not a single molecule. Ingredient molecular weights cannot be added to describe a vial or establish evidence for the blend.
MF: not assigned · MW: not assigned · Structure: not assigned
Catalogued ingredients: NAD+ · MOTS-c · 5-Amino-1MQ. The supplier must specify the amount and identity of each ingredient.
Registered clinical trials
Studies registered on ClinicalTrials.gov that list NAD+ / MOTS-c / 5-Amino-1MQ as an intervention. Studies that only measure the molecule as a biomarker, or use it only as a comparator or background arm for another drug, are excluded. A registration describes a planned or completed protocol; it does not report a result. Active studies are listed first.
This combination is not registered as a single studied intervention. Registered trials of individual ingredients are listed on their own profiles.
Human intervention studies
Selected studies in which participants received NAD+ / MOTS-c / 5-Amino-1MQ, with their indexed or reviewed study type. Check the original article for the formulation, population and controls. Studies that only measured the molecule, or used it as a comparator, are listed separately below and are not counted as intervention studies.
No human study that administered this compound was retained in this selected bibliography. This is a documented evidence gap in our selection, not proof that no study exists.
Preclinical research, reviews & other publications
Animal studies, laboratory experiments, reviews and other indexed papers answer different questions. A review is secondary evidence; a case report does not estimate how often an outcome occurs.
No additional matching publication was retained. The search links below allow further investigation; they are not evidence that a study exists.
NAD+ / MOTS-c / 5-Amino-1MQ supplier sources
Scientific sources describe molecules and experiments. The commercial links below identify recorded supplier packages. A publication or chemical database entry does not verify the seller, purity, sterility or contents of a lot. Some links are affiliate links; see our disclosure.
No priced supplier offers are currently available in this catalog view. The research record remains available independently of stock.
Reference sources & further reading
The citations above link directly to publication records. Encyclopedia links are background reading and are not used to establish clinical effectiveness.
Search for additional research
These links run searches; their results have not been individually reviewed and can include unrelated compounds.
Research information is not a dosing guide or a recommendation for personal use. Study findings are specific to the formulation, population and methods tested. Read our source and correction policy.
Ingredient and related research
5-Amino-1MQ
C10H11N2+
159.21 g/mol · PubChem CID 950107
3 selected publications · 0 human intervention studies
MOTS-c
C101H152N28O22S2
2174.6 g/mol · PubChem CID 146675088
6 selected publications · 0 human intervention studies · 1 registered trial
NAD+
C21H27N7O14P2
663.4 g/mol · PubChem CID 5892
1 selected publication · 1 human intervention study · 7 registered trials
Small molecule · highest stage: Phase 2